Dupuytren's Disease — assessment and management in Brisbane
Dupuytren's disease thickens the fascia in the palm, forming nodules and cords that can gradually pull one or more fingers inward toward the palm. It usually progresses slowly and often needs no treatment for many years.

Dupuytren’s disease affects the palmar fascia — the fibrous tissue layer just under the skin of the palm. Over time this tissue thickens and shortens, sometimes forming cords that tether one or more fingers into a bent position (a Dupuytren’s contracture). The ring and little fingers are most often affected, though any finger or the thumb can be involved.

It usually progresses very slowly over years, and in many people it stays mild enough that no treatment is needed. Assessment is useful to document the nodules, cords and any contracture, and to track whether it is changing over time. A practical guide is whether you can lay your hand flat on a table.

This is a structural condition of the fascia, so the image-guided injection treatments used for tendon and joint problems do not reverse it. When a contracture begins to limit hand function, referral to a hand surgeon is appropriate to discuss options such as collagenase injection, needle aponeurotomy or surgery. Because outcomes tend to be better when treated earlier, it is worth being assessed rather than waiting until the contracture is advanced.

Common symptoms

  • Firm lumps (nodules) or pitting in the skin of the palm
  • Thick cords of tissue under the skin of the palm
  • One or more fingers gradually bending toward the palm
  • Difficulty fully straightening a finger or laying the hand flat
Evidence-informed treatment summary

How our treatment options may fit for Dupuytren's Disease

The options below include the treatments offered at The Back Pain Doctor. Listing a treatment does not mean it is recommended for this condition. The evidence, likely benefit and role of each option are considered against the diagnosis, examination findings, imaging where appropriate, patient goals, risks, cost and alternatives.

Foundation

Diagnosis, education and progressive rehabilitation

This is the starting point for most musculoskeletal conditions.

The priority is to identify the likely pain generator, explain the condition clearly, modify aggravating load and build a realistic plan to restore strength, movement and confidence.

Evidence is condition-specific; it is not a universal pain treatment.

Shockwave is best framed as an adjunct where the diagnosis fits. It is generally more established for selected tendon and plantar heel pain presentations than for many joint or nerve conditions.

Read more

Evidence varies substantially by condition, tissue and preparation method.

PRP may be discussed in selected tendon or joint presentations. It should not be presented as a guaranteed regenerative treatment, and uncertainty, cost and alternatives should be discussed.

Read more

Best used for specific inflammatory or irritable pain generators, usually for short-term relief.

An injection may help when a joint, bursa, tendon sheath or other defined structure is driving symptoms. It is not a cure and needs to be weighed against risks, recurrence and the need for rehabilitation.

Read more

Clinical evidence is still developing and guideline support is limited.

EMTT may be discussed as an adjunct in selected presentations, but should be presented with clear uncertainty and never as a replacement for diagnosis, load management or rehabilitation.

Read more
Selected cases

Prolotherapy

Evidence is condition-specific and generally less established than exercise-based care.

Prolotherapy may be considered in carefully selected chronic ligament, tendon or joint-related pain presentations, but it is not a first-line treatment.

Read more

Most relevant when focal myofascial pain is a clear contributor.

Trigger point treatment may reduce pain from focal muscle spasm or myofascial tenderness. It should be paired with movement restoration, strength work and recurrence prevention.

Read more

Relevant only when the history and examination support nerve irritation or entrapment.

Nerve-focused treatment may be discussed when there is a plausible peripheral nerve pain generator. Progressive weakness, major neurological deficit or red flags require a different pathway.

Read more

This is general information only. Suitability is assessed individually. Treatments with limited or condition-dependent evidence may still be discussed, but only with clear explanation of uncertainty, expected benefit, risks, cost and alternatives. Red flags, progressive neurological symptoms or suspected serious pathology require a different pathway.

Frequently asked questions

What causes Dupuytren's disease?
The exact cause is not fully known, but genetics is the strongest factor and it often runs in families. It is more common with increasing age, in men, and in people of northern European ancestry, and is associated with diabetes and alcohol use.
Does it always need treatment?
No. It usually progresses slowly and many people never need treatment. Assessment is considered when a finger contracture starts to interfere with hand function, and outcomes are generally better when this is addressed earlier.
What are the treatment options?
There is no cure, but options to reduce a troublesome contracture include collagenase injection, needle aponeurotomy and surgery, all performed by a hand surgeon. This page is for information; management is individualised and may involve referral.

Ready for a clearer plan for your back or musculoskeletal pain?

Book an assessment with Dr Joshua Hatch.

Your assessment focuses on understanding the likely source of your pain and the most appropriate non-surgical options for your diagnosis, with the aim of reducing pain and improving function.

Book an appointment
Book an appointment with the Back Pain Doctor
Book now Call